Cardiomedics

Cardiomedics is a medical device company specializing in non-invasive circulatory support technologies, specifically External Counterpulsation (ECP) therapy. Founded in 1984, the company was a pioneer in the field, securing the first FDA clearance for an ECP system designed to treat chronic stable angina. Their flagship product, the Cardiomedics ECP System, works by applying sequential pressure to the lower limbs to increase blood flow to the heart and reduce its workload. The company serves a global market, providing equipment, clinical training, and technical support to hospitals and cardiology practices. Cardiomedics continues to focus on expanding the clinical applications of ECP for conditions such as congestive heart failure and cardiogenic shock.